WS Audiology delivered organic revenue growth of 8% and improved EBITDA by 36% in Q3 2022/23
Highlights Q3 2022/23
- WSA delivered organic revenue growth of 8% (4% reported) to EUR 612 million driven by broad-based growth across all regions.
- Reported EBITDA of EUR 120 million (margin 19.7%) increased by EUR 32 million or 36% compared to last year.
Highlights 9M 2022/2023
- In the first nine months of the fiscal year, WSA delivered organic revenue growth of 6% (6% reported) to EUR 1,852 million with reported EBITDA of EUR 362 million (margin of 19.5%).
- The results are in line with WSA’s FY guidance of 5-8% organic revenue growth and reported EBITDA margin increase by 1-2 percentage-points.
WS Audiology CEO, Eric Bernard, said:
“We are pleased with the Q3 results, which are in line with our expectations and confirm that we are on track to meet our full year guidance. Growth was solid and broad-based across all regions, and we are pleased that our multi-brand-, multi-channel strategy and innovative product portfolio continued to deliver strong performance.”